Cargando…
LRRK2 inhibition potentiates PARP inhibitor cytotoxicity through inhibiting homologous recombination‐mediated DNA double strand break repair
PARP inhibitors induce DNA lesions, the repair of which are highly dependent on homologous recombination (HR), and preferentially kill HR‐ deficient cancers. However, cancer cells have developed several mechanisms to transform HR and confer drug resistance to PARP inhibition. Therefore, there is a g...
Autores principales: | Chen, Lifeng, Hou, Jing, Zeng, Xiangyu, Guo, Qiang, Deng, Min, Kloeber, Jake A, Tu, Xinyi, Zhao, Fei, Wu, Zheming, Huang, Jinzhou, Luo, Kuntian, Kim, Wootae, Lou, Zhenkun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908045/ https://www.ncbi.nlm.nih.gov/pubmed/33784003 http://dx.doi.org/10.1002/ctm2.341 |
Ejemplares similares
-
A novel UCHL(3) inhibitor, perifosine, enhances PARP inhibitor cytotoxicity through inhibition of homologous recombination-mediated DNA double strand break repair
por: Song, Zhiwang, et al.
Publicado: (2019) -
The deubiquitinase USP36 Regulates DNA replication stress and confers therapeutic resistance through PrimPol stabilization
por: Yan, Yuanliang, et al.
Publicado: (2020) -
USP52 regulates DNA end resection and chemosensitivity through removing inhibitory ubiquitination from CtIP
por: Gao, Ming, et al.
Publicado: (2020) -
Syk-dependent alternative homologous recombination activation promotes cancer resistance to DNA targeted therapy
por: Zhou, Qin, et al.
Publicado: (2023) -
DNA end resection and its role in DNA replication and DSB repair choice in mammalian cells
por: Zhao, Fei, et al.
Publicado: (2020)